Public Company News

2026 ASCO Preview | Results from Phase III Study of Anbenitamab (KN026) Combined with HB1801 in Neoadjuvant Treatment for Breast Cancer Selected for LBA Oral Presentation

SUZHOU, China, April 22, 2026 /PRNewswire/ -- Alphamab Oncology (stock code: 9966.HK) today announced that the significant results from the Phase III clinical study (KN026-004) of HER2 bispecific antibody Anbenitamab Injection (KN026), independently developed by the Company, and co-developed with...

2026-04-22 14:10 903

XCMG Hydrogen-Powered Heavy Truck Completes "Hydrogen Marathon" Verification, Advancing Low-Carbon Heavy Transport

XUZHOU, China, April 22, 2026 /PRNewswire/ -- As Earth Day underscores this year's theme, "Our Power, Our Planet," global momentum toward low-carbon transition continues to accelerate. Against this backdrop, XCMG's hydrogen-powered heavy truck has successfully completed China's first full-indust...

2026-04-22 13:53 2995

Rockwell Automation Brings Industry Leaders Together at ROKLive Jakarta 2026, Shaping the Future of Industrial Operations

Highlighting innovations in AI, digitalization and energy management, the event explored how emerging technologies are transforming Indonesia's industrial operations JAKARTA, Indonesia, April 22, 2026 /PRNewswire/ -- Rockwell Automation, the world's largest company dedicated to industrial automa...

2026-04-22 13:30 2995

Kelun-Biotech Announces Three Clinical Study Results Selected for Oral Presentations at 2026 ASCO Annual Meeting

CHENGDU, China, April 22, 2026 /PRNewswire/ -- The 2026 American Society of Clinical Oncology (ASCO) Annual Meeting will be held in Chicago from May 29 to June 2. In this meeting, Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (6990.HK) will present results from three clinical studies, includi...

2026-04-22 08:59 2712

Case Report of Mabwell's Nectin-4 targeting ADC (9MW2821) in Cervical Cancer Published in The New England Journal of Medicine

SHANGHAI, April 22, 2026 /PRNewswire/ -- Mabwell (688062.SH), an innovation-driven biopharmaceutical company with a fully integrated industrial chain, announced that a recent clinical case report on its self-developed novel Nectin-4 ADC (bulumtatug fuvedotin, R&D code: 9MW2821) for the treatment ...

2026-04-22 08:00 2772

Innovent to Present New Clinical Data of IBI363(PD-1/IL-2α-biased bispecific fusion protein) at the 2026 ASCO Annual Meeting

SAN FRANCISCO and SUZHOU, China, April 21, 2026 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of oncology, cardiovascular and metabolic, autoimmun...

2026-04-22 08:00 2375

ViGenCell's VT-EBV-N Selected for Oral Presentation at ASCO 2026

Phase 2 study of EBV-specific T cell therapy to be presented at a leading oncology meeting SEOUL, South Korea, April 21, 2026 /PRNewswire/ -- ViGenCell Inc. (KOSDAQ: 308080), a clinical-stage biotechnology company based in South Korea focused on advanced cell therapies, today announced that resu...

2026-04-22 07:30 2269

Health In Tech to Present at the Market Movers Investor Summit

STUART, Fla., April 21, 2026 /PRNewswire/ -- Health In Tech, Inc. (Nasdaq: HIT) (the "Company"), an AI-enabled InsurTech platform company, today announced that it will be participating in the Market Movers Investor Summit on Tuesday, May 5, 2026. The Company's presentation, led by Julia Qian, CFO...

2026-04-22 04:00 3410

CATL Unveils Six Major Innovations: Multi-Chemistry Systems to Redefine New Energy Mobility Experience

BEIJING, April 22, 2026 /PRNewswire/ -- CATL today hosted its Super Technology Day in Beijing, unveiling third-generation Shenxing Superfast Charging Battery, third-generation Qilin Battery, Qilin Condensed Battery, second-generation Freevoy Super Hybrid Battery, Naxtra Sodium-ion Battery and a f...

2026-04-22 02:41 3439

HCLTech FY26 revenue up 3.9%, led by increasing demand for Advanced AI

Annualized Advanced AI revenue at $620M; FY26 services revenue up 4.8% in CC; TCV of new deal wins at $9.3B NEW YORK and NOIDA, India, April 22, 2026 /PRNewswire/ -- HCLTech , a leading global technology company, today reported financial results for the fourth quarter a...

2026-04-22 01:44 3015

Annual general meeting of AB SKF

GOTHENBURG, Sweden, April 21, 2026 /PRNewswire/ -- The annual general meeting of Aktiebolaget SKF was held on Tuesday 21 April 2026. The income statement and balance sheet and the consolidated income statement and consolidated balance sheet were adopted. A dividend of SEK 7.75 per share to be pa...

2026-04-21 22:00 2326

Joyson Electronics Unveils First-ever Sustainability Dual Reports, Sets 2040 Core-Operations Net-Zero Target

HONG KONG and NINGBO, China, April 21, 2026 /PRNewswire/ -- Joyson Electronics (0699.HK) has, for the first time, released two sustainability-related reports in tandem—its Sustainability Report 2025 and Nature-related Disclosures Report 2025. It continues to embed sustainability into its strategy...

2026-04-21 21:48 3775

Massimo Expands Fleet Network and Advances Second-Generation Autonomous Patrol Platform

Growing deployment across facility-based environments and enhanced autonomous capabilities support broader commercial applications GARLAND, Texas, April 21, 2026 /PRNewswire/ -- Massimo Motor today announced the continued expansion of its electric vehicle fleet network across municipal, commerci...

2026-04-21 21:25 4152

Cognizant and OpenAI Partner to Reshape Enterprise Software Engineering with Codex

Recognized by OpenAI for its AI builder capabilities, Cognizant is embedding Codex across its global software engineering organization and working with OpenAI to bring Codex-driven development to clients across industries.  TEANECK, N.J., April 21, 2026 /PRNewswire/ -- Cognizant (NASDAQ: CTSH) a...

2026-04-21 21:15 4875

EZGO Takes Full Legal Ownership of Its Self-Built Changzhou Manufacturing Facility to Scale Production

CHANGZHOU, China, April 21, 2026 /PRNewswire/ -- EZGO Technologies Ltd. (Nasdaq: EZGO) ("EZGO" or the "Company"), a short-distance transportation solutions provider in China, today announced that its subsidiary, Jiangsu EZGO New Energy Technology Co., Ltd., has received the real estate ownership ...

2026-04-21 21:15 3067

Insilico Medicine Announces Industry's First Longevity Board to Accelerate AI-Driven Aging Research for Drug Discovery

CAMBRIDGE, Mass., April 21, 2026 /PRNewswire/ -- Insilico Medicine ("Insilico", 3696.HK), a clinical-stage generative artificial intelligence (AI)-driven biotechnology company, today announced the strategic formation of the industry's first Longevity Board (Board). The initiative provides scienti...

2026-04-21 21:05 3436

NYSE Content Update: UiPath Celebrates Five-Year Listing Anniversary at NYSE

NYSE issues a pre-market daily advisory direct from the trading floor. NEW YORK, April 21, 2026 /PRNewswire/ -- The New York Stock Exchange (NYSE) provides a daily pre-market update directly from the NYSE Trading Floor. Access today's NYSE Pre-market update for market insights before trading begi...

2026-04-21 20:55 3944

Getinge Interim Report January-March 2026: Organic growth, strong cash flow and regulatory milestone

GOTHENBURG, Sweden, April 21, 2026 /PRNewswire/ -- "We succeeded in surpassing last year's record-breaking first quarter with organic growth in both net sales and order intake," says Mattias Perjos, President & CEO at Getinge. The medtech company's net sales increased organically by 0.8% while th...

2026-04-21 20:36 2120

Minaris Delivers 100% Manufacturing and Release Success for Chimeric Therapeutics' CDH17 Autologous CAR‑T Program

Five-year collaboration supports consistent clinical supply for Phase 1A/1B GI cancer study PHILADELPHIA and MELBOURNE, Australia, April 21, 2026 /PRNewswire/ -- Minaris, a global cell and gene therapy (CGT) contract development and manufacturing organization (CDMO) and multimodality biosafety t...

2026-04-21 20:00 2306

Celltrion to present seven abstracts in inflammatory bowel disease (IBD) at 2026 Digestive Disease Week® (DDW)

* Seven abstracts accepted for presentation include data from long-term follow-up studies and a post-hoc analysis of the pivotal LIBERTY studies (LIBERTY-CD and LIBERTY-UC) of ZYMFENTRA® (infliximab-dyyb) * Findings emphasize clinical decision-making in long-term management of inflammatory bo...

2026-04-21 20:00 2791
1 ... 78910111213 ... 1665